Tips

美迪西归纳收纳了5月生物制品医疗机械产业例会供对比互动交流。与此同时，我国将进度表直接参与海上下8场例会：

IVC2024第四届核酸疫苗与创新疫苗研发工艺论坛

IVC2024第四个届核酸预防针与改革创新预防针生产制造施工工艺论坛图片将于2026年7月1-2祝日东莞龙城会议通知：80余名厂家史学家，1000位行业领域竞争对手邀您共襄高峰会，2天3个分会场全心全力开发预防针盛典。

2024（第四届）类器官大会

为推向全球性类五官行业的成长 ，催进探究的人员深入到交换合作方式，浅议类五官探究行业的重中之重科学合理情况，2024（4届）类五官会谈会—类五官与抗癌新药产品开发暨ISoOR 2024全球性类五官出行高峰会谈将于202几年2月7-8祝日全球伤害雅居乐万豪侯爵酒吧闭幕。

第七届成都生物医药创新者峰会

美迪西总裁合理官彭双清教导将担当讨论区网举办来宾，毒理实验部精致主任委员邹汉军博土将叁加GLP1治疗药物开发技术讨论区网高并发表内容主题演讲题目。

第七届成都生物医药创新者峰会将于2024年3月7-8日于成都举办，会议将涵盖ADC，改良型新药，小分子新药，GLP-1药物研发领域前沿动态，并聚焦最新临床进展。旨在打破行业的信息壁垒，推动创新多元发展！届时美迪西商务团队将在A01展位等候您的莅临。

第九届细胞生物产业大会

组织神经癌肿瘤癌细胞怪物制品家产看作战略重点性兴新家产，近几这几年来不停的刷快优惠政策的支撑和市場的重视。2023也组织神经癌肿瘤癌细胞怪物制品科技领域获得巨大超过的大半年，发改局进行发布的的《家产的结构校准制定方案总目录（2026年本）》，表扬组织神经癌肿瘤癌细胞家产的进展，象征着着国内组织神经癌肿瘤癌细胞怪物制品家产请稍等与全.球前端融入。组织神经癌肿瘤癌细胞怪物制品家产在2026年的具体表现，为市場氛围励精图治了决心，也为比较多的的研究项目立项造成 期盼和转折。这里大环境下，第八届生殖神经元膜动物制品领域年会暨第五届国动物制品微生物制药转型升级进行进行合作年会将于2025年9月8-9号在武汉盛大网络举行！每一次年会由武汉市生殖神经元膜冶疗技術医学会、正和展会协力阻止，助推生殖神经元膜动物制品领域转型升级快速发展，进行进行合作共盈！

SOT 63rd Annual Meeting and ToxExpo

More Science, More Networking, More Everything in 2024Medicilon is excited to attend and exhibit at the conference. Dr. Haizhou Zhang, president of preclinical R&D unit at Medicilon, will be available at the booth. Dr. Zhang holds a PhD in Toxicology from Indiana University, USA. He is a pharmaceutical industry veteran with over 20 years of experience in the R&D of small and large molecule drugs.Medicilon's state-of-the-art preclinical facilities hold full AAALAC accreditation. With advanced platforms and experienced scientists, Medicilon guarantees the utmost professionalism in drug efficacy and safety assessments services, adhering to global regulatory standards. Offering services from stand-alone preclinical studies to comprehensive IND-enabling packages, Medicilon provides flexible solutions to efficiently support biotech and pharmaceutical clients in reaching their developmental milestones.

14th World ADC London

Europe's Longest Standing & Definitive Antibody-Drug Conjugate Event！Antibody-drug conjugates are an important class of therapeutics for the treatment of cancer. ADCs are coming of age with a remarkable surge in recent times, that has marked a turning point in their development.In the formulation of ADC preclinical integrated research plan, Medicilon has in-depth communication with customers. The backbone of scientific research has combined the characteristics of each case with years of practical experience and technical accumulation, and carefully submitted high-quality experimental plans and results to customers. Medicilon started ADC non-clinical research in 2014. As of the end of 2023, We has successfully assisted in the clinical approval of 20+ ADC drugs by NMPA and/or FDA and has 30+ ADC projects under development.

2024 NEDMDG Spring Meeting

Recent interest in the delivery of therapeutics to the brain has dramatically increased with the advent of new ADCs and other targeted delivery vehicles for the treatment of dementias and glioblastoma. In addition, subcutaneous delivery has been found to be an effective mode of ADC delivery, but the bioavailability in humans has been difficult to predict. These two factors have driven an increasing interest in the human cell-based in vitro models for screening novel delivery methods to gain mechanistic insight into the factors that control either entry into the brain or systemic bioavailability of subcutaneously delivered drugs. In this presentation Dr. Roger Kamm will present the models specifically developed for both applications and the potential for iPS cell-derived systems. The benefits and current limitations of these models will also be addressed with the goal of stimulating an active discussion.The Seminar is Sponsored by Medicilon.

IDC2024

从目前“改革转型升级”调整布局看看，内卷频发，靶点聚集，差异化寡头垄断猛烈：内卷在其中该怎样才能做到扶摇直上九萬里而不被卷进涡流，却变为了改革转型升级药人目前最需用思考的1点。

BIOCHINA2024(EBC)

美迪西新碳原子业务类型盛典将于11月16日有峰会哺乳期间拉开帷幕，美迪西毒理研发部副经理裁曾宪成硕士生与毒理研发部高級主任医师邹汉军硕士生应邀参加潜在表主題演讲内容。

BIOCHINA2024第9届易贸生物学工业博览会(EBC)将于2021年6月14-16日有杭州全国博览公司ABCDEFG馆隆重召开。BIOCHINA2024(EBC)坐版启航，以“博览会-研讨会-过程”五大管理体制，面积30,000人、550家展会公司、500场学术性该报告。我司美迪西商務微商团队将在C3馆C060-C061标准展位排队您的亲临。

ACS Spring 2024

Many Flavors of Chemistry！Founded in 1876 and chartered by the U.S. Congress, ACS is one of the world's largest scientific organizations with more than 200,000 individuals in its global community across 140 countries.With the rapid development of the global pharmaceutical market and the division of labor in the industry, the process of drug discovery and development is becoming increasingly refined. This makes specialized outsourcing an important strategic choice for pharmaceutical companies. In the early stages, companies often use FTE models for the synthesis of structural fragments and candidate compounds to accelerate the drug screening process. Medicilon provides comprehensive chemistry research services covering all stages of your project requirements, and we offer cooperation through both FFS and FTE models.

2024美迪西创新药物产业生态合作大会

200四年，美迪西注册成立。回望廿载，美迪西保持潜心一走式医学前研制开发服务的机构投建，与中国人革新医疗企业业携手同心携手同行，相互之间闪光灵程业内的成长与锐变。202历经四年，为进这一步着力推进我国的国抗癌新药品牌的优质化量进步前景，美迪西创抗癌新药品品牌防水加盟交流会将于202历经四年1月18日为西安承办。500多位品牌新精英共聚沪上，为创抗癌新药品品牌防水建言献策，相同不断探索我国的国国医疗企业业加盟进步前景新格局与挑战。

BIO-Europe Spring

Connecting the global biopharma community to elevate life science partnershipsBIO-Europe Spring, the premier springtime partnering event, brings together over 3,700 attendees from 2,000+ companies to engage in 20,000 one-to-one meetings.Medicilon provides comprehensive one-stop R&D services for pharmaceutical enterprises and scientific research institutions around the world. Based on the key requirements of drug R&D, we focus on meeting the demand for innovation and development. With our experience in serving domestic and foreign biomedical industries, we have built an integrated platform covering key technologies in drug discovery, pharmaceutical research, and preclinical research, to provide a comprehensive preclinical R&D service for the global biomedical industry. By the end of 2023, we have served more than 2000 clients globally with more than 300 INDs approved in China and more than 80 INDs approved overseas.

SIT 2024第六届小分子药物创新与合作大会

这届研讨会信息将凝聚小原子核式结构药剂的不断科技创新性设计规划、项目立项攻略 、制作与MAH、转为医学研究、合作项目共盈、PROTAC、共价治理和改善剂、PPI、变构治理和改善剂、多肽偶联药剂、多肽刷脂药剂、 AI与CADD注力口服药设计规划十分他新技術等，走向小原子核式结构药剂生产制造的焦点方向，概览眼下化学式不断科技创新性药生产制造新行势，极力于击破业内人士的围合配置，解决业内人士内卷，进一步推动不断科技创新性多块大洋趋势!一起尽在小原子核式结构药剂的第四季度工业研讨会!

SABPA Event

8th Annual Frontiers in Therapeutics and Diagnostics (FTD) ForumSABPA FTD annually brings together the latest in groundbreaking research, cutting-edge drugs, and industry trends within the biopharma sector. The event's broad spectrum of topics provides a platform to engage in vibrant discussions and valuable networking opportunities. The forthcoming 8th FTD Conference is set to shine a spotlight on three revolutionary domains in the field of metabolism disease and oncology: GLP-1, ADC, and Minimal Residual Disease (MRD), each representing the forefront of innovations in therapeutics and diagnostics.

2024生物药创新与质量大会

生态学药是当今最具投资的实用价值的医疗细分化教育领域，在国内在研抗癫痫药物大体中的正比在近几年中逐渐下降。伴着一个国家各医疗证策的大力支持和资本公司的培育，国内生态学医疗全新来临了新的时代契机。菌物体工程体学医疗器械业科研开发与自主信息化一些技木的的进步是菌物体工程体学医疗器械业工业转型的条件。为利于菌物体工程体学医疗器械业工业转型，更稳地利于菌物体工程体学技木产学讨论会，由在我国食药利于会产品检验检定协会理事、河南省菌物体工程体学药剂学与团伙菌物体工程体学学学习、河南省基础医学习肿瘤药物剂量剂量研究正规非常专业常务协会和河南省基础医学习菌物体工程体学肿瘤药物剂量剂量正规非常专业常务协会协办人，药检汇协同协办人，由合肥奇易社会限制公司协办的“BIQC2024菌物体工程体学药自主信息化与的效率博览会”将于2025年三月在广州叁加。博览会以“自主信息化驱动高的效率转型”为重题，修建企业合作讨论会公司，集中各国发改局“十四五六”菌物体工程体学划算转型开发计划，探究新努力奋斗房产革命中菌物体工程体学医疗器械业工业转型的新构思、新路径分析。以mRNA狂犬疫苗、多肽肿瘤药物剂量剂量、抗体阳性偶联等前沿性菌物体工程体学技木、菌物体工程体学药科研开发自主信息化与的效率有效控制开始深入浅出讨论会和研讨会。

第二届中国生物药分析与质量峰会

由于菌物药技能的不间断發展，药物剂量的性质越变越小，世界各国的菌物药研制开发与生产方式也進入到的飞速延长的朝代。微微微生物学工程工程制品体体学药的大分子量大、面积构成苛刻、淡化类型和突变体繁多等基本特征，给口服药剂学习与产品保持造成 了非常的大挑戰。血清、血浆、吐沫、排尿和组建等微微微生物学工程工程制品体体学产品中口服药剂安全性能浓度测得是口服药剂产品研制的核心部门，有效的微微微生物学工程工程制品体体学学习步骤相对于口服药剂药代扭测力、毒代扭测力、微微微生物学工程工程制品体体学等效性等口服药剂的临床上前学习供应前提条件。化学、钙镁离子、微微微生物学工程工程制品体体学学微生物学工程工程制品、免役学特征参数及涉及到的实行推荐措施学习等非常的错综复杂，有效的产品管理措施与保持管理体制是微微微生物学工程工程制品体体学药产品研制及产出关键点青睐与探析的导向。微微微生物学工程工程制品体体学药学习与产品锋会BioAQ是口服药剂学习、产品及核查层面核心的互动手机平台，专业专注于力促微微微生物学工程工程制品体体学医药公司业内产、学、研技能互动与协作。锋会贯穿目前微微微生物学工程工程制品体体学药成长 前景和核查条件，对单抗、双/多抗、资产重组/深度融合血清、肿瘤细胞的开展、什么是基因的开展、核酸口服药剂等的微微微生物学工程工程制品体体学学习步骤与产品保持实行推荐和渗入探析。

marketing@czchengteng.com
微信或邮件联系我们